Minnema M, Nasserinejad K, Hazenberg B, et al. HOVON 104: results from a multicenter, prospective phase II study of bortezomib based induction treatment followed by autoogous stem cell transplantation in patients with de novo AL amyloidosis. EHA 2017, abstract S411.
Clofarabine kan anthracyclines en etoposide vervangen bij remissie-inductie AML
sep 2019 | Leukemie